Literature DB >> 17640892

Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells.

Jiang Han1, Daniel Kim, Kevin V Morris.   

Abstract

siRNAs targeted to gene promoters can direct epigenetic modifications that result in transcriptional gene silencing in human cells. It is not clear whether the antisense strand of the siRNAs bind directly to DNA or to a sense-stranded RNA transcript corresponding to the known promoter region. We present evidence that an RNA polymerase II expressed mRNA containing an extended 5' untranslated region that overlaps the gene promoter is required for RNA-directed epigenetic modifications and transcriptional silencing of the RNA-targeted promoter. These promoter-associated RNAs were detected by their hybridization to the antisense strand of the complementary promoter-directed siRNA. Antisense phosphorothioate oligodeoxynucleotides were used to degrade the promoter-associated RNA transcripts, the loss of which abrogated the effect of siRNA-mediated transcriptional gene silencing, as well as the complexing of the siRNA with the silent state histone methyl mark and the promoter-associated RNA. These data demonstrate that low-copy promoter-associated RNAs transcribed through RNAPII promoters are recognized by the antisense strand of the siRNA and function as a recognition motif to direct epigenetic silencing complexes to the corresponding targeted promoters to mediate transcriptional silencing in human cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640892      PMCID: PMC1924466          DOI: 10.1073/pnas.0701635104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Components of the DNA methylation system of chromatin control are RNA-binding proteins.

Authors:  Linda Jeffery; Sara Nakielny
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

2.  Transcriptional silencing of nonsense codon-containing immunoglobulin minigenes.

Authors:  Marc Bühler; Fabio Mohn; Lukas Stalder; Oliver Mühlemann
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

3.  Antisense transcription in the mammalian transcriptome.

Authors:  S Katayama; Y Tomaru; T Kasukawa; K Waki; M Nakanishi; M Nakamura; H Nishida; C C Yap; M Suzuki; J Kawai; H Suzuki; P Carninci; Y Hayashizaki; C Wells; M Frith; T Ravasi; K C Pang; J Hallinan; J Mattick; D A Hume; L Lipovich; S Batalov; P G Engström; Y Mizuno; M A Faghihi; A Sandelin; A M Chalk; S Mottagui-Tabar; Z Liang; B Lenhard; C Wahlestedt
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

4.  RNA polymerase II is required for RNAi-dependent heterochromatin assembly.

Authors:  Hiroaki Kato; Derek B Goto; Robert A Martienssen; Takeshi Urano; Koichi Furukawa; Yota Murakami
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

5.  RNA maps reveal new RNA classes and a possible function for pervasive transcription.

Authors:  Philipp Kapranov; Jill Cheng; Sujit Dike; David A Nix; Radharani Duttagupta; Aarron T Willingham; Peter F Stadler; Jana Hertel; Jörg Hackermüller; Ivo L Hofacker; Ian Bell; Evelyn Cheung; Jorg Drenkow; Erica Dumais; Sandeep Patel; Gregg Helt; Madhavan Ganesh; Srinka Ghosh; Antonio Piccolboni; Victor Sementchenko; Hari Tammana; Thomas R Gingeras
Journal:  Science       Date:  2007-05-17       Impact factor: 47.728

6.  Characterization of the regulatory elements in the promoter of the human elongation factor-1 alpha gene.

Authors:  N Wakabayashi-Ito; S Nagata
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

7.  Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.

Authors:  Qing-Yin Wang; Changhong Zhou; Karen E Johnson; Robert C Colgrove; Donald M Coen; David M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

8.  Small interfering RNA-induced transcriptional gene silencing in human cells.

Authors:  Kevin V Morris; Simon W-L Chan; Steven E Jacobsen; David J Looney
Journal:  Science       Date:  2004-08-05       Impact factor: 47.728

9.  2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.

Authors:  Byong Hoon Yoo; Elena Bochkareva; Alexey Bochkarev; Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2004-04-02       Impact factor: 16.971

Review 10.  Antisense and/or immunostimulatory oligonucleotide therapeutics.

Authors:  S Agrawal; E R Kandimalla
Journal:  Curr Cancer Drug Targets       Date:  2001-11       Impact factor: 3.428

View more
  130 in total

1.  Identification and characterization of a noncoding RNA at the mouse Pcna locus.

Authors:  Ji-Yeon Lee; Abdul Aziz Khan; Hyehyun Min; Xinnan Wang; Myoung Hee Kim
Journal:  Mol Cells       Date:  2012-01-02       Impact factor: 5.034

2.  A novel nuclear miRNA mediated modulation of a non-coding antisense RNA and its cognate sense coding mRNA.

Authors:  John J Rossi
Journal:  EMBO J       Date:  2011-11-02       Impact factor: 11.598

Review 3.  Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-01-27       Impact factor: 5.486

Review 4.  Promoter-associated RNAs and promoter-targeted RNAs.

Authors:  Bing-Xue Yan; Jin-Xia Ma
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

5.  Transcriptional silencing by hairpin RNAs complementary to a gene promoter.

Authors:  Yongjun Chu; Roya Kalantari; David W Dodd; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 6.  Minireview: Switching on progesterone receptor expression with duplex RNA.

Authors:  Bethany A Janowski; David R Corey
Journal:  Mol Endocrinol       Date:  2010-06-30

Review 7.  Long antisense non-coding RNAs and their role in transcription and oncogenesis.

Authors:  Kevin V Morris; Peter K Vogt
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 8.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

Review 9.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.

Authors:  Marc S Weinberg; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 10.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.